期刊文献+

糖耐量正常的向心性肥胖患者8-异前列腺素水平及其与胰岛素抵抗的关系

The level of 8-iso-prostaglandin F2α(8-iso-PGF2α)in the central obese patients with normal glucose tolerance (NGT) and its relationship with insulin resistance
原文传递
导出
摘要 目的观察向心性肥胖患者的8-异前列腺素(8-iSo-PGF2α)水平及其与胰岛素抵抗的关系。方法筛选糖耐量正常的向心性肥胖患者(包括胰岛素抵抗与无胰岛素抵抗者)及正常对照组。分别测定血清8-iso-PGF2α,丙二醛(MDA),游离脂肪酸(FFA)等。结果向心性肥胖组8-iso-PGF2α、MDA、胰岛素抵抗指数(HOMA-IR)、FFA均显著高于对照组(P<0.05)。8-iso-PGF2α差异最显著(P<0.01),且与FFA、BMI及甘油三酯(TG)呈显著正相关。胰岛素抵抗亚组的8-iso-PGF2α水平显著高于无胰岛素抵抗亚组。多元回归分析显示,8-iso-PGF2α与HOMA-IR相关性最强。结论糖耐量正常的向心性肥胖患者氧化应激增强,且氧化应激是胰岛素抵抗的重要危险因素,循环中8-iso--PGF2α水平能更好地反映其程度。 Objective To investigate the level of 8 iso-prostaglandin F2α (8-iso-PGF2α) and its relationship with insulin resistance in central obese patients with NGT. Methods Two hundred and twenty-two subjects were enrolled and divided into two groups: central obese group (n=123) and normal control group(NC, n:99). The central obese group was subdivided into insulin resistance(IR) group and non-IR group. Serum 8-iso-PGF2α, malondialdehyde (MDA), free fatty acids (FFA), IL-6, TNF-α, and lipid were measured. Results Compared with the control group, the levels of 8-iso-PGF2α(P〈0. 001), body mass index(BMI), waist circumference(WC), triglyceride (TG), cholesterol (TC), high density lipoprotein(HDL), FFA, MDA and insulin resistance index (HOMA-IR) significantly increased in obese group(all P〈0. 05), and they increased even more in IR sub-group than those in non-IR sub-group. The level of 8-iso-PGF2α had independently positive correlation with HOMA-IR. Conclusion Oxidative stress increases in central obese patients with NGT, and it plays an important role in insulin resistance. The level of serum 8-iso-PGF2α is a better parameter indicating the extent of oxidative stress.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2011年第4期246-249,共4页 Chinese Journal of Diabetes
基金 辽宁省教育厅科学技术基金项目(20060999)
关键词 向心性肥胖 8-异前列腺素 氧化应激 胰岛素抵抗 Central obesity 8-iso-prostaglandins F2α Oxidative stress Insulin resistance
  • 相关文献

参考文献10

  • 1Mezzetti A, Cipollone F, Cuccurullo F, et al, Oxidative stress and cardiovascular complications in diabetes ~ isoprostanes as new markers on an old paradigm. Cardiovasc Res, 2000, 47: 475-488.
  • 2袁托亚,任保军.冠心病患者8-异前列腺素F_(2α)变化及其与血脂的相关性研究[J].中国循环杂志,2006,21(4):273-275. 被引量:2
  • 3Helmersson J, Arnlov J, Vessby B, et al. Serum selenium predicts levels of F2isoprostanes and prostaglandin F2alpha in a 27 year follow-up study of Swedish men . Free Radic Res, 2005, 39: 763-770.
  • 4Jawson JA, Rokach J, Fitzgerald GA. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biod Chem, 1999, 274: 24441-24444.
  • 5杨文英,杨兆军,李光伟,邢小燕.联合测量腰臀围比值(或腰围)和血压可预测代谢综合征[J].中华内分泌代谢杂志,2005,21(3):227-229. 被引量:93
  • 6韩萍,张咏言,卢雁,何冰,张微,夏菲.不同种类游离脂肪酸对大鼠胰岛素抵抗的影响[J].中华内分泌代谢杂志,2007,23(1):16-19. 被引量:13
  • 7Weinbrenner T, Schr6der H, Escurriol V, et at. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr, 2006,83 : 30-35.
  • 8Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation, 2007,116 : 1234-1241.
  • 9Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxi- dative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 2004, 114: 1752-1761.
  • 10沈兴平,邹森彪,吴豪杰,张岩.肥胖患者氧化应激和脂肪细胞因子变化[J].细胞与分子免疫学杂志,2008,24(7):721-723. 被引量:23

二级参考文献31

  • 1宋光耀,马慧娟,叶蔚,姜玲玲,刘惠敏,王智华,张文杰.不同糖耐量人群血浆脂肪酸谱与胰岛素抵抗[J].中华内分泌代谢杂志,2004,20(3):197-199. 被引量:18
  • 2LingLi,Gang-YiYang.Effect of hepatic glucose production on acute insulin resistance induced by lipid-infusion in awake rats[J].World Journal of Gastroenterology,2004,10(21):3208-3211. 被引量:10
  • 3沈兴平,李娟,严钟德.肥胖2型糖尿病患者血清E-选择素水平与氧化应激的关系[J].中国病理生理杂志,2006,22(10):2040-2043. 被引量:12
  • 4Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985,28:412-419.
  • 5World Health Organisation. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part I: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
  • 6Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes, 2003,52:2160-2167.
  • 7Alexander CM, Landsman PB, Teutsch SM, et al. Third National Health and Nutrition Examination Survey (NHANES Ⅲ); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES Ⅲ participants age 50 years and older. Diabetes, 2003,52:1210-1214.
  • 8Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 2002,287:356-359.
  • 9Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation, 2003,108:1546-1551.
  • 10Janssen I, Katzmarzyk PT, Ross R.Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr, 2004,79:379-384.

共引文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部